A landmark selection of review articles published this week in IOP Publishing's Journal of Physics D: Applied Physics, 'Progress in Applications of Magnetic Nanoparticles in Biomedicine', shows just how far magnetic nanoparticles for application in biomedicine have come and what

The awards are part of DOE's investment to support the development of new solar energy technologies and the rapid deployment of available carbon-free solar energy systems.

Two labs report that nanoparticle-delivered gene therapy successfully suppressed ovarian tumor growth in mice.

Mit der Spitze eines Rastertunnelmikroskops schalten Forscher einzelne Atome von 'Spin up' auf 'Spin down' um - einfach indem sie den Abstand der Spitze zum Atom aendern.

A novel method of detection of cervical cancer cells has been developed by Clarkson University Professor Igor Sokolov's group, an affiliate of the University's Nanoengineering and Biotechnology Laboratories Center (NABLAB).

Under the umbrella of the Juelich Aachen Research Alliance (JARA), from 2010 the Centre for Microscopy and Spectroscopy with Electrons will be operating a unique electron microscope with a world-beating resolution of 50 billionths of a millimetre.

Imitating photosynthesis in plants? If we were to accomplish this, mankind would have a little less to worry about. Chemists have now made progress on the road to achieving artificial photosynthesis.

Since 2004, 50 million euros has been invested in high-calibre research and commercially-oriented development work as part of the Austrian NANO initiative. This approach has launched numerous patents and inventions onto the international market. These developments will be presented at

Good news for heterogeneous catalysis and the hydrogen economy: computers can now be used to make accurate predictions of the reactions of (hydrogen) molecules with surfaces.

Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells.

To augment its dedicated OEM engineering resources, Ocean Optics, an industry leader in miniature photonics, has launched www.OceanOEM.com, devoted to the needs of its OEM customers.

Prof. Luisa De Cola vom Physikalischen Institut der Westfaelischen Wilhelms-Universitaet Muenster erhaelt eine besonders prestigetraechtige Auszeichnung des Europaeischen Forschungsrats (ERC): den hoch angesehenen 'Advanced Researcher Grant' 2009.

Applied Materials, Inc., the leading supplier of equipment and services to the solar photovoltaic (PV) industry, announced today that it has acquired substantially all the assets, including the intellectual property, of Advent Solar, Inc. for an undisclosed cash amount.

U.S. Senators Charles E. Schumer and Kirsten Gillibrand today announced that the Senate has approved the FY10 Commerce, Justice, Science, and Related Agencies Appropriations Bill which includes $500,000 for the University at Albany's College of Nanoscience and Engineering.

The Top-level Research Initiative is launching a call for user-driven research projects within the sub-programme 'Energy Efficiency with Nanotechnology' in the beginning of 2010. The Top-level Research Initiative is the largest joint Nordic research and innovation initiative to date. The

Diamon-Fusion International, Inc. (DFI Nanotechnology), global developer and exclusive licensor of patented hydrophobic nanotechnologies, announced today the signing of another key strategic alliance and license agreement in Hong Kong with Decorlinks Ltd.

The speakers' presentations from the OECD 'Conference on Potential Environmental Benefits of Nanotechnology: Fostering Safe Innovation-Led Growth' are now available online on the OECD site.

that correct the spherical aberration of the lens in order to achieve even higher resolution is currently being assembled at the Electron Microscopy Centre (EMEZ) at ETH Zurich.

Beneq announces the first continuous mode Atomic Layer Deposition (ALD) research tool commercially available, the TFS 200R.

Abraxis Health, a fully-integrated personalized healthcare division of Abraxis BioScience, Inc., today announced the dedication of its new manufacturing facility in Phoenix, Arizona.